Adir Et Compagnie

Beatrice Guardiola-Lemaitre

Pierre Renard

Gerard Adam

Daniel Lesieur

Patrick Depreux

Said Yous

Bruno Pfeiffer

Gerald Guillaumet

Gerard Coudert

Tchao Podona

Daniel Henri-Caignard

Philippe Delagrange

Eric Fourmaintraux

Daniel-Henri Caignard

Ousmane Diouf

Daniel H Caignard

The invention relates to a compounds selected from these of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and a medicinal product containing the same useful for treating a melatoninergic disorder.

Alkylated (hetero) cyclic compounds

The invention relates to a compound selected from those of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and Medicinal product containing the same useful for treating a disorder of the melatoninergic system.

Method of treating disorders of the melatoninergic system and a certain

The invention relates to a compound selected from those of formula (I): ##STR1## wherein Ar, n, B and A are as defined in the description, to their optical isomers, and to their addition salts there of with a pharmaceutically-acceptable acid or base. The compounds are useful for treating or preventing anxiety and depression.

(Aryl(alkyl)carbonyl)-heterocyclic compounds and their use in the

A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are as defined in the specification, and

Naphthylethylureas and naphthylethylthioureas

A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are as defined in the specification, and medicinal products containing the same which are useful in treating or in preventing a disorder of the melatoninergic system.

The invention relates to a compound selected from those of general formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined in the specification, an optical isomer, and an addition salt thereof with a pharmaceutically-acceptable base. Medicinal product which is useful in the treatment of disorders linked to abnormal melatonin activity.

Naphthylalkylamines

A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are as defined in the specification, and medicinal products containing the same which are in treating or in preventing a disorder of the melatoninergic system.

Naphthylethylureas

The invention relates to compounds of the formula I: ##STR1## in which R.sub.1 is as defined in the description, their optical isomers and their addition salts with a pharmaceutically-acceptable acid or base, and medicinal products which are useful for treating Central Nervous System disorders.

Thiochroman compounds

The invention relates to a compound selected from those of formula (I): ##STR1## wherein Ar, n, B and A are as defined in the description, to their optical isomers, and to their addition salts there of with a pharmaceutically-acceptable acid or base. Medicinal product which is useful for treating pain and treating or preventing pathologies which require psychotropic agents.

(Aryl(alkyl)carbonyl)-heterocyclic compounds, compositions and use

A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are defined in the specification, and medicinal products containing the same which are useful in treating or in preventing a disorder of the melatoninergic system.

Growing community of inventors

Neuilly sur Seine, France

Beatrice Guardiola-Lemaitre